Samuel N. Hazen - 29 Oct 2021 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: CEO, Director
Signature: /s/ Natalie Harrison Cline, Attorney-in-Fact
Issuer symbol: HCA
Transactions as of: 29 Oct 2021
Net transactions value: -$24,748,086
Form type: 4
Filing time: 02 Nov 2021, 19:34:41 UTC
Next filing: 01 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Options Exercise	$7,321,421	+152,625	+51%	$47.97^*	451,454	29 Oct 2021	Direct
transaction	HCA	Common Stock	Tax liability	$19,483,283	-77,790	-17%	$250.46	373,664	29 Oct 2021	Direct
transaction	HCA	Common Stock	Sale	$2,153,528	-8,581	-2.3%	$250.96	365,083	02 Nov 2021	Direct	F1
transaction	HCA	Common Stock	Sale	$9,635,230	-38,260	-10%	$251.84	326,823	02 Nov 2021	Direct	F2
transaction	HCA	Common Stock	Sale	$797,465	-3,159	-0.97%	$252.44	323,664	02 Nov 2021	Direct	F3
holding	HCA	Common Stock						813,320	29 Oct 2021	By LP

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HCA	Stock Appreciation Right	Options Exercise	$0	-82,500	-100%	$0.000000^*	0	29 Oct 2021	Common Stock	82,500	$47.97	Direct	F4
transaction	HCA	Stock Appreciation Right	Options Exercise	$0	-70,125	-100%	$0.000000^*	0	29 Oct 2021	Common Stock	70,125	$47.97	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.24 to $251.23, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.24 to $252.23, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.24 to $252.76, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.
F5	The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.